Cerebral Inc., a fast-growing mental health and medication management startup based in San Francisco, recently announced it will stop prescribing most controlled substances to new patients starting this Friday....
A bipartisan coalition of U.S. Senators is pressing the Biden administration to make permanent the COVID-19-era regulatory changes that have expanded access to virtual...
Psychedelics are steadily gaining recognition as promising alternative therapies for various mental health conditions. A recent report from Magellan Rx Management, the pharmacy benefits...
The U.S. Centers for Medicare & Medicaid Services (CMS) has released its proposed payment rule for fiscal year 2023, focusing on Medicare reimbursement for...
Cerebral Inc., a fast-growing virtual mental health company, is making a significant shift in its workforce strategy with its "Cerebral Care Coordinator Outsourcing" plan....
The Biden administration’s federal budget proposal for fiscal year 2023 includes a landmark investment of $4.77 billion dedicated to transforming mental health and substance...